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ABSTRACT
Functional genomic elements are marked by char-
acteristic DNA and histone modification signatures.
How combinatorial chromatin modification states are
recognized by epigenetic reader proteins and how
this is linked to their biological function is largely
unknown. Here we provide a detailed molecular anal-
ysis of chromatin recognition by the lysine demethy-
lase KDM2A. Using biochemical approaches we iden-
tify a nucleosome interaction module within KDM2A
consisting of a CXXC type zinc finger, a PHD do-
main and a newly identified Heterochromatin Protein
1 (HP1) interaction motif that mediates direct binding
between KDM2A and HP1. This nucleosome interac-
tion module enables KDM2A to decode nucleosomal
H3K9me3 modification in addition to CpG methyla-
tion signals. The multivalent engagement with DNA
and HP1 results in a nucleosome binding circuit in
which KDM2A can be recruited to H3K9me3-modified
chromatin through HP1, and HP1 can be recruited to
unmodified chromatin by KDM2A. A KDM2A mutant
deficient in HP1-binding is inactive in an in vivo over-
expression assay in zebrafish embryos demonstrat-
ing that the HP1 interaction is essential for KDM2A
function. Our results reveal a complex regulation of
chromatin binding for both KDM2A and HP1 that is
modulated by DNA- and H3K9-methylation, and sug-
gest a direct role for KDM2A in chromatin silencing.
INTRODUCTION
The genetic material of eukaryotic cells is stored in the nu-
cleus in the form of chromatin, a nucleoprotein complex
composed of DNA and histone proteins. DNA and his-
tones both carry chemical modifications creating distinct
combinatorial signatures that encode epigenetic informa-
tion and recruit effector proteins regulating chromatin func-
tion (1). These effector proteins must be able to integrate
signals from both DNA and histone modifications in order
to translate this information into physiological responses.
How chromatin modification states are interpreted by epi-
genetic readers and how this is linked to biological processes
is largely unknown.
A factor that has the potential to decode different nu-
cleosomal modification signatures is the histone H3K36-
demethylase KDM2A, the first jumonji C (JmjC) his-
tone demethylase to be identified (2). KDM2A is a multi-
domain protein consisting of the JmjC demethylase do-
main, a CXXC-type zinc finger (ZnF), a PHD domain, an
F-box and several C-terminal leucine-rich repeats (LRR).
In addition to the full-length protein KDM2A is ex-
pressed in several shorter isoforms, the most prominent
of which––KDM2ASF (for short form)––spans from the
CXXC-ZnF to the C-terminus and lacks the catalytic
JmjC domain (3–5). KDM2A was shown to recognize
nucleosomal linker DNA containing unmethylated CpG-
dinucleotides via its CXXC-ZnF. This interaction is blocked
by DNA methylation (3,6,7). KDM2A was also found to
interact with heterochromatin protein 1 (HP1) proteins (8)
and HP1 was shown to recruit KDM2A to H3K9me3-
modified nucleosomes (3).KDM2A, therefore, processes in-
formation from both DNA and histone modification marks
and has the potential to distinguish between different chro-
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matin states. KDM2Awas shown to have a function at CpG
island promoters (7) and in heterochromatin maintenance
(8), and to regulate rRNA gene transcription during star-
vation (5,9). There is increasing evidence that KDM2A is
involved in cancer formation (10–16) but the underlying
molecular mechanisms remain unclear.
Here, we present a detailed molecular analysis of how
KDM2A is recruited to chromatin and how it distinguishes
between different nucleosomal modification states. Using in
vitro reconstituted modified nucleosomes and nucleosome
interaction assays we have mapped an extended chromatin
recognition module in KDM2A comprising the CXXC-
ZnF, the PHD domain and a newly identified variant HP1-
binding motif. We demonstrate that this HP1-binding motif
mediates a direct interaction betweenKDM2Aand theHP1
chromo shadow domain. The resulting multivalent interac-
tion enables a complex binding circuit on chromatin involv-
ing both factors which is modulated by DNA- and H3K9-
methylation and which allows KDM2A and HP1 to be tar-
geted to chromatin in a DNA or H3K9me3-independent
manner, respectively. The HP1-motif is enriched for can-
cer mutations and we find that an HP1 binding-deficient
KDM2A mutant is inactive in an in vivo overexpression as-
say in zebrafish embryos underscoring the importance of
HP1 binding for KDM2A function. Our results reveal a
complex regulation of chromatin binding for bothKDM2A
and HP1, and suggest a direct role for KDM2A in chro-
matin silencing.
MATERIALS AND METHODS
Tissue culture and immunofluorescence
293T, BHK and HeLa cells were grown in DMEMmedium
supplemented with 10% FBS. 293T cells were transfected
using calcium phosphate or polyethylenimine (PEI) pro-
tocols, and BHK and HeLa cells were transfected us-
ing PEI. Mouse ES cells (mixed 129/SV-C57B1/6J WT
cells and Suv39h dn derivative (17)) were grown on 0.2%
(w/v) gelatin-coated dishes in DMEM medium contain-
ing high glucose, 15% (v/v) fetal calf serum, 100 U/ml
penicillin, 100 g/ml streptomycin, 2 mM L-glutamine, 0.1
mM-mercaptoethanol, 1× non-essential amino acids, and
LIF. Transfections with FLAG-GFP-KDM2A expression
constructs were performed using Fugene HD transfection
reagent (Promega) according to the manufacturer’s recom-
mendations for the transfection of mouse stem cells. For
immunofluorescence (IF) analysis, cells were collected by
trypsinization and immobilized on slides by cytospin. The
cells were then washed in PBS and fixed in PBS containing
0.3% Triton X-100 and 3.7% formaldehyde for 10 min. Af-
ter two washes in PBS, cells were blocked in blocking buffer
(PBS containing 10% milk; 3% BSA; 0.2% Tween and 0.2%
NP-40) for 20 min at RT. The cells were then incubated for
1 h with 0.5 g/ml of each primary antibody (rabbit anti-
GFP for GFP-KDM2A detection and mouse anti-HP1)
and for 30 min with DAPI and the secondary antibodies
where required in the dark. The cells were mounted in Pro-
Long Gold DAPI-free mounting medium (LifeTechnolo-
gies). Images were acquired with a TCS SP5 laser scanning
confocal microscope (LeicaMicrosystemsGmbH) and pro-
cessed using ImageJ. Twenty to fifty cells from one to three
experiments for each construct and condition were scored
based on co-localization of the GFP-KDM2A signal with
DAPI dense foci.
Extract preparation and co-immunoprecipitations
293T whole cell extracts were prepared ∼36 h after trans-
fection by rotating the cells in extraction buffer (20 mM
Hepes pH 7.5; 300 mM NaCl; 1 mM EDTA; 20% glyc-
erol; 0.5% NP40; 1 mM DTT and complete protease in-
hibitors [Roche]) for 1 h at 4◦C and removing cell debris by
centrifugation. HeLa S3 cells were grown in suspension in
RPMI 1640 medium containing 10% FBS. Cells were har-
vested at a density of 0.5–0.8×106 cells/ml and nuclear ex-
tracts were essentially prepared as described (18). All ex-
tracts were snap frozen and stored in aliquots at−80◦C. For
co-immunoprecipitation of endogenous KDM2A and HP1
proteins (Figure 2A) nuclear extracts were prepared from
HeLa cells using a modified protocol combining the soluble
and chromatin-bound fractions. Briefly, nuclear pellets were
resuspended in five pellet volumes of low salt solubiliza-
tion buffer (20 mM Hepes pH7.5; 150 mM NaCl; 1.5 mM
MgCl2; 0.2 mMEDTA; 25%Glycerol; 0.1%NP40; 0.5 mM
DTT; 0.5 mM PMSF and complete protease inhibitors)
supplemented with 200 U/ml Benzonase (Sigma) and in-
cubated at 37◦C for 15 min. After a 10 s sonication step on
ice insoluble chromatin was pelleted and the supernatant
kept on ice (Fraction I). The pellets were resuspended in
high salt solubilization buffer (20 mM Hepes pH7.5; 500
mM NaCl; 1.5 mM MgCl2; 0.2 mM EDTA; 25% glycerol;
0.1% NP40; 0.5 mM DTT; 0.5 mM PMSF and complete
protease inhibitors) and rotated at 4◦C for 1 h. After three
10 s sonication steps debris was pelleted by centrifugation
and the resulting supernatant (Fraction II) combined with
Fraction I. Precipitates were removed by centrifugation and
the nuclear extracts were snap frozen and stored in aliquots
at−80◦C. Immunoprecipitationswere carried outwith 1mg
of nuclear extract in a total volume of 1 ml in the presence
of 50 g of ethidium bromide. Extracts were pre-cleared
with Dynabeads Protein G (Invitrogen) for 1 h at 4◦C and
then incubated with anti-GFP or anti-KDM2A antibod-
ies for 3 h at 4◦C. Antibody-bound proteins were captured
with Dynabeads Protein G for 2 h at 4◦C. After five washes
with wash buffer (20 mM Hepes pH7.5; 150 mM NaCl;
0.2 mM EDTA; 20% glycerol; 0.1% NP40 and complete
protease inhibitors) bound proteins were eluted in sample
buffer and analyzed by SDS-PAGE and immunoblot. For
co-immunoprecipitation of FLAG-GFP-tagged KDM2A
and FLAG-tagged HP1 (Figure 2B and C) transiently
transfected HeLa cells were lysed in high salt extraction
buffer (20 mMHepes pH 7.5; 375 mMNaCl; 1 mMEDTA;
20% glycerol; 0.5% NP40; 1 mM PMSF and complete pro-
tease inhibitors) for 2 h at 4◦C. Cell debris was removed by
centrifugation and the extracts were then diluted 2.5-fold
with 20mMHepes pH7.5; 1mMEDTA; 20% glycerol; con-
taining 0.5 mM PMSF and complete protease inhibitors to
adjust the NaCl concentration to 150 mM. The diluted ex-
tracts were rotated for 2 h at 4◦C with 20 l of magnetic
GFP-Trap beads (Chromotek) in order to immunoprecip-
itate GFP-tagged proteins. After four washes with wash
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Figure 1. Mapping of nucleosome binding sites within KDM2A. (A) Schematic representation of the assembly of modified nucleosomes and nucleosome
pull-downs. Modified histone H3.1 was prepared by native chemical ligation and assembled into nucleosomes together with purified core histones H2A,
H2B and H4 and nucleosomal 601-DNA. Nucleosomes were immobilized on streptavidin beads via the biotinylated DNA and incubated with protein ex-
tracts or recombinant proteins to identify modification-binding factors. (B) Recruitment of KDM2A to H3K9me3-modified nucleosomes is stimulated by
HP1 and counteracted by CpG-methylation. HeLa S3 nuclear extracts were incubated with immobilized modified nucleosomes as indicated. Binding reac-
tions were supplemented with recombinant purifiedHP1 orGST as a control. 4% of the nuclear extract input and 20% of the pull-downs were separated by
SDS-PAGE and nucleosome-boundKDM2A andHP1were detected by immunoblot. Equal loading was confirmed by Coomassie stain andmodification
of histone H3 was verified by immunoblot against H3 tri-methyl lysine marks. Both, the full length and the short isoform of KDM2A (KDM2ASF) show
increased binding to H3K9me3-modified nucleosomes, which is strongly stimulated by addition of HP1 and reduced by CpG-methylation. (C) Mapping
of nucleosome binding domains in KDM2A. Unmodified or H3K9me3-modified nucleosomes were immobilized on streptavidin beads and incubated with
293T whole cell extracts overexpressing wild-type (WT) FLAG-GFP-tagged KDM2A or point/deletion mutants as indicated. All binding reactions were
supplemented with recombinant purified HP1. Forty percent of each input and pull-down were separated by SDS-PAGE and binding of KDM2A was
detected by immunoblot against the FLAG tag. The S603D point mutation disrupts binding of the CXXC-ZnF to CpG dinucleotides (37) and the PHD
C>A mutant contains C620A and C623A point mutations disrupting the structural integrity of the PHD domain. In the F-box mutant amino acids
893 to 933 and in the LRR mutant amino acids 1000 to 1118 are deleted. Loading controls can be found in Supplementary Figure S2A. (D) Mapping
of a nucleosome interaction module within KDM2A. Nucleosome binding reactions were carried out as above using FLAG-GFP-tagged full length (FL)
KDM2A or N- or C-terminal deletion mutants including amino acids as indicated. Loading controls can be found in Supplementary Figure S2B. (E)
Schematic representation of the domain structure of KDM2A and the point and deletion mutants used in Figure 1C and D.
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Figure 2. KDM2Abinds to theHP1 chromo shadowdomain via a variantHP1 interactionmotif. (A)KDM2A interacts with allHP1 isoforms. Endogenous
KDM2Awas immunoprecipitated fromHeLa nuclear extracts consisting of the soluble and chromatin-bound nuclear fractions. One percent of the nuclear
extract input and 30% of the IPs were separated by SDS-PAGE and co-immunoprecipitating endogenous HP1 proteins were detected by immunoblot
against HP1 ,  and  , respectively. The KDM2A antibody immunopreciptates both the full length and the short form of KDM2A (KDM2ASF). The
asterisks denote bands derived from the antibodies used for IP. (B) KDM2A interacts with HP1 via its LxVxL HP1-binding motif. FLAG-GFP-tagged
WT KDM2A or point/deletion mutants were co-expressed with FLAG-tagged HP1 in HeLa cells. KDM2A was immunoprecipitated from whole cell
extracts using GFP-trap beads and bound KDM2A and HP1 were detected by immunoblot against the FLAG tag. (C) HP1 interacts with KDM2A
via the chromo shadow domain. FLAG-GFP-tagged WT KDM2A was co-expressed with FLAG-tagged WT or mutant HP1 in HeLa cells as indicated.
KDM2A was immunoprecipitated from whole cell extracts using GFP-trap beads and bound KDM2A and HP1 were detected by immunoblot against
the FLAG tag. (D) The interaction between KDM2A and HP1 is direct. Recombinant purified HP1 and the purified KDM2A nucleosome recognition
module (KDM2A543-811) weremixed and then separated by size exclusion chromatography. Formation of a complex is indicated by a shifted co-migration of
both proteins in highermolecular weight fractions. The figure shows chromatograms of the complex and the individual proteins andCoomassie-stained gels
of individual fractions separated by SDS-PAGE. (E) Size exclusion chromatography shows that HP1 fails to form a complex with a KDM2A nucleosome
recognition module harbouring the V801A/L803Amutation and confirms that the KDM2A/HP1 interaction is mediated by the LxVxL-interaction motif.
The chromatogram of the complex formed between the WT proteins is shown for comparison (green trace). (F) Schematic representation of the domain
structure of HP1 indicating the positions of inactivating point mutations in the chromo domain (CD) and chromo shadow domain (CSD).
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buffer bound proteins were eluted in sample buffer and an-
alyzed by SDS-PAGE followed by immunoblot.
In vitro KDM2A/HP1 interaction assays
For analysis of KDM2A543-811/HP1 complexes by size ex-
clusion chromatography 50 g of each protein were mixed
in a total volume of 50 l and incubated for 15 min at 4◦C.
The complete binding reactionwas separated on a Superdex
200 Increase 3.2/300 column in gel filtration buffer (50
mMTris pH7.5, 100 mMNaCl, 5 mM -mercaptoethanol)
collecting 50 l fractions. Ten microliters of each frac-
tion were analyzed by SDS-PAGE followed by Coomassie
staining. For analysis of the interaction between full-length
KDM2A cancer mutants and recombinant HP1 FLAG-
GFP-tagged KDM2A variants were transiently expressed
in 293T cells and whole cell extracts were prepared in ex-
traction buffer (20 mM Hepes pH7.5; 300 mM NaCl; 1
mM EDTA; 20% glycerol; 0.5% NP40; 1 mM PMSF and
complete protease inhibitors). For each mutant, three sep-
arate extracts were prepared and pooled to even out dif-
ferences in expression levels. Relative expression levels of
KDM2A cancer mutants in the pooled extracts were deter-
mined by quantitative immunoblot against the FLAG tag
using a LAS4000 mini chemiluminescence imaging system
and ImageQuant software (GE Healthcare). KDM2A ex-
pressing extracts were then adjusted with mock-transfected
extracts to achieve similar expression levels for all mutants.
For pull-downs 0.5 mg (mutant screen) or 0.2 mg (WT ver-
sus K793N) of extract were rotated with anti-FLAG M2
agarose beads (Sigma) in extraction buffer for 3 h at 4◦C
to capture FLAG-GFP-tagged KDM2A. The beads were
washed twice with extraction buffer followed by one wash in
binding buffer (20 mM HEPES pH 7.9, 150 mMNaCl, 0.2
mM EDTA, 20% glycerol, 0.1% NP40 and complete pro-
tease inhibitors) and immobilized KDM2A was then ro-
tated in 200 l binding buffer with recombinant purified
HP1 as indicated for 2 h at 4◦C. After three washes in
binding buffer bound proteins were eluted in sample buffer
and analyzed by SDS-PAGE and immunoblot. Chemilumi-
nescence signals were detected using a LAS4000 mini imag-
ing system and quantified using ImageQuant software (GE
Healthcare).
Reconstitution of modified nucleosomes and nucleosome pull-
downs
Modified human histone H3.1 proteins were generated by
native chemical ligation and assembled into nucleosomes
together with purified human H2A, H2B and H4 and bi-
otinylated 601-DNAas described (3). CpG-methylated 601-
DNA was generated using M.SssI CpG methyltransferase
(NEB). For nucleosome pull-downs from HeLa S3 nuclear
extracts (Figure 1B) nucleosomes corresponding to 15 g
of octamer were immobilized on 80 l Dynabeads My-
One Streptavidin T1 (Invitrogen) and incubated with 0.5
mg HeLaS3 nuclear extract in 1 ml of binding buffer (20
mM HEPES pH7.9, 150 mM NaCl, 0.2 mM EDTA, 20%
glycerol, 0.1%NP40, 1 mMDTT and complete protease in-
hibitors) together with 6 g of recombinant HP1 or GST
for 4 h at 4◦C. After three washes in binding buffer, bound
proteins were eluted in sample buffer and analyzed by SDS-
PAGE followed by immunoblot or Coomassie staining.
Pull-downs from overexpressing 293T cell extracts were per-
formed with immobilized nucleosomes corresponding to
2.5 g of octamer and 1 g of recombinant HP1 (Fig-
ure 1C, D and Supplementary Figure S2A-C) or 5 g of
octamer and 2 g of recombinant HP1 (Supplementary
Figure S1) in a total volume of 0.5 ml of binding buffer
containing 10–20 l of 293T whole cell extract. The vol-
ume of 293T whole cell extract was adjusted with mock-
transfected extracts according to the expression levels of
individual KDM2A mutants/deletions. Nucleosome pull-
downs with purified proteins were carried out in 1 ml of
binding buffer as indicated in the figure legends. For Fig-
ure 3A and B, Supplementary Figure S4A and S4B nucle-
osomes corresponding to 2.5 g of histone octamer were
immobilized on streptavidin beads and incubated with 2 g
of WT or mutant full length FLAG-GFP-tagged KDM2A
and 2 g of HP1. For Figure 4A and B nucleosomes cor-
responding to 2.5 g of histone octamer were immobilized
on streptavidin beads and incubated with 2.5 g of WT or
mutant HP1 and/or 2.5 g of KDM2A543-811. For Sup-
plementary Figure S5 nucleosomes corresponding to 4 g
of histone octamer (∼40 pmol) were immobilized on strep-
tavidin beads and incubated with increasing amounts of
HP1 (0.05g; 0.5g; 5g; 40g) or KDM2A543-811 (0.12
g; 1.2 g; 12 g; 40 g) in the presence of either 23 g
of KDM2A543-811 (∼0.8 nmol; lanes 4–8 and 14–18) or 8
g of HP1 (∼0.4 nmol; lanes 24–28 and 34–38). After
three washes, bound proteins were eluted in sample buffer
and analyzed by SDS-PAGE followed by immunoblot or
Coomassie staining.
Fluorescent three hybrid (F3H) assay
BHK cells with an integrated lac operator array (19) were
seeded on coverslips in six-well plates and triple-transfected
with the corresponding fluorescent protein fusion plasmids
and a plasmid expressing LacI-fused GFP binder protein
(pGBP-LacI) (20). The transfected cells were fixed with
3.7% formaldehyde, stained with DAPI, and mounted on
slides in Vectashield medium (Vector Laboratories). Images
of the cells were acquired with a TCS SP5 laser scanning
confocal microscope (Leica Microsystems GmbH) using a
63× objective. 405, 488 and 561 nm lasers were used to
excite the DAPI, GFP and mRuby2, respectively. Signals
were recorded with a pixel size of 80 nm by PMT detec-
tors. For quantitative assays, a spinning disc confocal mi-
croscope UltraView VOX (PerkinElmer Inc.) was used. For
each imaging field, Z stack images with a 1 m step size
were acquired for a total depth of 6 m and then projected
according to themaximum intensity. The projectionwas an-
alyzed with imageJ. To quantify the interaction between the
two fluorescent fusion proteins, the fluorescence intensity
ratio between the mRuby2 and GFP at the lacO spot were
calculated. In brief, the spot area was segmented accord-
ing to the GFP signal, and the average fluorescence inten-
sity of this area in both GFP and mRuby2 channels was
measured (Ispot GFP and Ispot mRuby2) and the average inten-
sity of the whole nucleus (Inucleus GFP and Inucleus mRuby2) was
subtracted to eliminate the impact of different expression
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Figure 3. HP1 recruits KDM2A to H3K9me3-modified nucleosomes independently of DNA binding. (A) HP1-mediated recruitment of KDM2A to
H3K9me3-modified nucleosomes independently of the ZnF and PHD domains. Unmodified or H3K9me3-modified nucleosomes were immobilized on
streptavidin beads and incubated with WT HP1 and WT full length FLAG-GFP-tagged KDM2A or mutants in the ZnF (S603D) or PHD (PHD C>A)
domains or the LxVxL motif (V801A/L803A) as indicated. 15% of the KDM2A inputs and pull-downs and 3% of the HP1 input were separated by
SDS-PAGE and nucleosome-bound KDM2A and HP1 were detected by immunoblot. Equal loading was confirmed by immunoblot against Histone
H3 and H3K9me3 modification of histone H3 was verified by immunoblot against the H3 tri-methyl lysine 9 mark. The apparent stronger binding of
the V801A/L803A mutant is due to the difference in the input compared to the WT pull-downs. (B) Recruitment of KDM2A to H3K9me3-modified
nucleosomes via HP1 is mediated through its LxVxL motif. Unmodified or H3K9me3-modified nucleosomes containing either unmethylated or CpG-
methylated 601-DNA were immobilized on streptavidin beads and incubated with WT HP1 and WT full length FLAG-GFP-tagged KDM2A or the
V801A/L803A mutant as indicated. Binding of KDM2A and HP1 to the nucleosomes was detected as described in Figure 3A.
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Figure 4. KDM2A mediates H3K9me3-independent binding of HP1 to nucleosomes. (A) KDM2A recruits HP1 to unmodified nucleosomes via
the LxVxL motif. Unmodified or H3K9me3-modified nucleosomes were immobilized on streptavidin beads and incubated with WT HP1 and WT
KDM2A543-811 or the V801A/L803A mutant as indicated. Fifteen percent of the KDM2A543–811 inputs and pull-downs and 3% of the HP1 input were
separated by SDS-PAGE and nucleosome-bound KDM2A543-811 and HP1 were detected by immunoblot. Equal loading was confirmed by Coomassie
stain. (B) Recruitment of HP1 to unmodified nucleosomes via KDM2A requires an intact chromo shadow domain. Nucleosome pull-downs were carried
out as described in Figure 4A with WT KDM2A543–811 and WT or mutant HP1 (V22M, I165K or W174A mutants) and as indicated.
levels between the channels and cells. The ratio of fluores-
cence intensity at the spot between mRuby2 and GFP were
then calculated by (Ispot mRuby2 − Inucleus mRuby2)/ (Ispot GFP −
Inucleus GFP), as an indication of interaction between the two
proteins.
Overexpression of human KDM2A in zebrafish embryos
Zebrafish embryos of the TLF (Tu¨pfel long fin) strain
were injected at the one cell stage with 3.6 nl of capped
polyadenylated mRNA (mMESSAGE mMACHINE T7,
Ambion) generated from human FLAG-GFP-tagged
KDM2A constructs (see Supplementary Methods) at a
concentration of 62.5 ng/l combined with 0.05% Phenol
Red (Sigma). Embryos were raised at 28.5◦C for 24 h
and then characterized based on their morphology. Dead
embryos and embryos with abnormal phenotypes were
classified into the abnormal category.
Statistical analysis of overexpression experiments
Overexpression experiments were analysed using Fisher’s
Exact Test. For the V801A/L803A vsWT experiment a 2×
3 contingency table was first used to assess if there was any
difference between any of the groups and then each pair-
wise comparison was performed. The P-values were then
adjusted for multiple testing using Bonferroni correction.
Sequence alignments, SNPs and cancer SNVs
KDM2A orthologues from species representing different
levels of phylogenetic depth (mouse, chicken, green anole,
Xenopus tropicalis, zebrafish) along with select paralogues
(human KDM2B, zebrafish Kdm2ab) and more distant
members of the same gene family (human FBXL19, Ciona
intestinalis ZF(CXXC)-1) were identified using Treefam
(TF106480; www.treefam.org) (21). Protein sequences were
downloaded fromEnsembl v75 (22) and aligned usingMus-
cle v3.8.31 (23). The alignment is provided as Supplemen-
tary File 1 in a CLC Main Workbench 6 format (CLC
Bio).Missense SNPs inKDM2A (ENSG00000173120) seg-
regating in the human population were obtained from
Ensembl v81 (22). Missense cancer SNVs were compiled
from Ensembl which includes COSMIC v71 (24) and
cBioPortal/TCGA (25,26), with redundant entries removed
after cross-checking tumor sample IDs. For TCGA data,
curated rather than automatically generatedMAFfiles were
used where available. Three variants were present as both a
cancer SNV and a SNP. These SNPs/SNVs were excluded
fromFigure 7A.A complete list of SNPs/SNVs inKDM2A
is provided as Supplementary Table S1.
RESULTS
KDM2A contains an extended nucleosome recognition mod-
ule
We previously identified KDM2A in a SILAC nucleo-
some affinity purification screen for nucleosome-binding
proteins with differential responses to DNA and histone-
methylation marks (3). We found KDM2A to be enriched
on nucleosomes bearing the heterochromatic H3K9me3-
modification and to be prevented from binding by DNA
methylation. We found that the binding to H3K9me3-
modified nucleosomes was mediated by HP1 proteins (3),
principle components of heterochromatin known to bind to
the H3K9me3-mark and to recruit other chromatin silenc-
ing factors (27,28). In an effort to further understand how
KDM2A is targeted to chromatin we set out to dissect the
binding mechanisms of KDM2A to modified nucleosomes.
We first assembled nucleosomes combining histone H3 tri-
methylated at lysine 4 or 9 generated by native chemical
ligation (29) and DNA methylated at CpG-di-nucleotides
and incubated these with HeLaS3 nuclear extracts (Fig-
ure 1A). As observed in our previous experiments KDM2A
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present in the extracts displayed basal binding to unmodi-
fied nucleosomes that was increased onH3K9me3-modified
nucleosomes and inhibited by CpG methylation (Figure
1B). KDM2A was reported to interact with all HP1 iso-
forms (8). Indeed, addition of purified recombinant HP1
resulted in strong recruitment of KDM2A to H3K9me3-
modified nucleosomes (Figure 1B). Overexpressed FLAG-
GFP-tagged KDM2A in 293T whole cell extracts recapitu-
lated the stimulation of binding by HP1 although enrich-
ment onH3K9me3-modified nucleosomes withoutHP1 ad-
dition was less pronounced, most likely due to the excess
of overexpressed KDM2A over endogenous HP1 proteins
(Supplementary Figure S1).
In order to identify the binding sites within KDM2A re-
quired for the nucleosome interactionwe incubated unmod-
ified and H3K9me3-modified nucleosomes with 293T ex-
tracts expressing mutant forms of KDM2A in the presence
of purified HP1. Systematic deletion and point mutants of
individual domains showed that both the ZnF and the PHD
domain were necessary for efficient nucleosome recognition
(Figure 1C and Supplementary Figure S2A). However, a
fragment encompassing only the ZnF and PHD domains
did not show strong interaction (Figure 1D and Supplemen-
tary Figure S2B) indicating the requirement for an addi-
tional binding determinant in KDM2A, possibly an HP1-
interaction motif. Since mutation of two apparent PxVxV
HP1-binding motifs (30,31) centred at position V530 and
V835 had no effect we set out to identify this site by system-
atic large-scale deletions (Figure 1D, E and Supplementary
Figure S2B). A mutant lacking the complete C-terminal se-
quence following the PHD domain lost efficient binding
while the previously described isoform KDM2ASF (3–5)
displayed binding properties similar to the full-length (FL)
protein, indicating the presence of an additional binding site
in the C-terminal region of KDM2A. Further C-terminal
deletions of the KDM2ASF variant revealed a minimal
nucleosome-interacting fragment ranging from amino acids
543–811. Removal of another 15 amino acids from the C-
terminus of this fragment resulted in loss of efficient nucleo-
some binding. Analysis of the sequence of these amino acids
indicated the presence of a variant LxVxL HP1-interaction
motif (Figure 7A) found in a minority of HP1-interacting
proteins (30). An alanine point mutant scan of the mo-
tif (Supplementary Figure S2C) identified valine 801 and
leucine 803 to be critical amino acids for efficient nucleo-
some binding of KDM2A (Figure 1C and Supplementary
Figure S2A). Thus, KDM2A harbours an extended ‘nucle-
osome recognition module’ ranging from amino acids 543–
811, which contains the CXXC-ZnF, the PHD domain and
a variant HP1 interaction motif, all of which are required
for efficient binding to H3K9me3-modified nucleosomes in
the presence of HP1.
KDM2A directly interacts with the HP1 chromo shadow do-
main via its LxVxL motif
To verify a potential direct interaction between KDM2A
and HP1 we first immunoprecipitated endogenous
KDM2A from HeLa nuclear extracts prepared by combin-
ing both soluble and chromatin-bound nuclear fractions.
Western blots against endogenous HP1 isoforms , , and
 demonstrated that KDM2A could co-immunoprecipitate
all three HP1 isoforms (Figure 2A).
We next investigated whether the LxVxL motif is in-
volved in this interaction. To this end we co-expressed var-
ious point and deletion mutants of FLAG-GFP-tagged
KDM2A (see Figure 1E) and FLAG-tagged HP1 (Fig-
ure 2F) in HeLa cells and immuno-precipitated KDM2A
from whole cell extracts via the GFP tag. Bound HP1
was detected by western blot against the FLAG tag (Fig-
ure 2B and C). These experiments demonstrate that the
V801A/L803A mutation in the LxVxL motif disrupts the
KDM2A/HP1 interaction (Figure 2B). A V22M point
mutant in the chromo domain (CD) of HP1 that inter-
feres with the interaction of HP1 with the histone H3 N-
terminal tail (32) retainedKDM2Abinding, whereas I165K
andW174A point mutations in the chromo shadow domain
(CSD) that interfere with the binding of HP1 to factors
containing P/LxVxV/L/M interaction motifs (30,33) dis-
rupted the binding to KDM2A (Figure 2C).
These findings were corroborated in a direct interaction
assay in which we incubated recombinantly purified HP1
with a purified version of the KDM2A nucleosome recog-
nition module ranging from the ZnF to the HP1 interaction
motif (amino acids 543–811). Separation of the proteins by
size exclusion chromatography showed the formation of a
KDM2A/HP1 complex demonstrating a direct interac-
tion between KDM2A and HP1 (Figure 2D). Further size
exclusion chromatography experiments using the KDM2A
V801A/L803A mutant, the HP1 I165K and W174A mu-
tants, and purified HP1 and HP1 (Figure 2E and Sup-
plementary Figure S3A-D) confirm direct binding between
KDM2A and all HP1 isoforms and that this interaction is
mediated by the CSD in HP1 and the LxVxL HP1 interac-
tion motif in KDM2A.
KDM2A and HP1 form a complex binding circuit on chro-
matin
The initial nucleosome binding experiments described
above were carried out in protein extracts. In order to
eliminate the influence of other factors present in the ex-
tracts on the interaction between KDM2A, HP1 and nu-
cleosomes we performed nucleosome pull-downs with pu-
rified components using recombinant HP1 and purified
full length FLAG-GFP-tagged KDM2A (Figure 3A, B and
Supplementary Figure S4C). In this purified system nu-
cleosome binding by wild-type KDM2A was independent
of HP1 or the H3K9me3-modification (Figure 3A, lanes
7–10) most likely through direct contacts of the CXXC-
ZnF with the linker DNA extending from the nucleosomes
used in our assays for ∼20 bp on either side. Adding nu-
clear extract to the binding reactions resulted in a strong
decrease in binding of recombinant KDM2A (Supplemen-
tary Figure S4A) indicating competition by other factors
present in the extract for binding sites on the nucleosomes.
Under these conditions KDM2A showed increased recruit-
ment to H3K9me3-modified nucleosomes when HP1 was
added to the binding reaction similar to overexpressed
KDM2A in 293T extracts. This increase was not observed
for the V801A/L803Amutant (Supplementary Figure S4B)
demonstrating that in situations in which competition lim-
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its access of KDM2A to the nucleosomes the number of
available binding sites between KDM2A and chromatin be-
comes critical for efficient recruitment. Using the inactivat-
ing point mutations in the ZnF (S603D) and the PHD do-
main (PHD C>A) in the purified system completely abol-
ished nucleosome binding by KDM2A (Figure 3A, lanes
12, 13 and 17, 18) confirming that the PHD domain plays
a crucial role in nucleosome recognition in addition to
the CXXC-ZnF, which is known to mediate binding to
CpG dinucleotides present in the linker DNA (6,7). The
V801A/L803A mutant in the HP1 interaction motif re-
tained the ability to bind to nucleosomes (Figure 3A, lanes
22 to 25) indicating that it is not directly involved in nucleo-
some recognition. Interestingly, both, the ZnF mutant and
the PHDmutant could be recruited to H3K9me3-modified
nucleosomes in the presence of HP1 (Figure 3A, lanes 15
and 20) pointing toward a DNA-independent recruitment
mechanism of KDM2A to chromatin via HP1.
In order to test this hypothesis further we performed
pull-down experiments with nucleosomes containing CpG-
methylated DNA. As expected, CpGmethylation abolished
KDM2A binding to nucleosomes (Figure 3B, lanes 9 and
10). However, KDM2A could be recruited to H3K9me3-
modified nucleosomes containing methylated DNA in the
presence ofHP1 (Figure 3B, lane 14). This bindingwas not
detected when using the V801A/L803Amutant (Figure 3B,
lane 23). These findings confirm a direct recruitment mech-
anism of KDM2A to chromatin via HP1 and that this bind-
ing is mediated through its LxVxL HP1 interaction motif.
We also detected a signal for HP1-binding to unmodi-
fied nucleosomes in the presence of KDM2A (Figure 3A,
lane 9 and Figure 3B, lane 11). This binding was absent
in the V801A/L803A mutant (Figure 3A, lane 24 and Fig-
ure 3B, lane 20) despite robust recruitment of this mutant
to the nucleosomes. This finding could be confirmed us-
ing the recombinant KDM2A543-811 nucleosome recogni-
tion module described above. Nucleosome pull-downs us-
ing WT and V801A/L803A mutant KDM2A543–811 (Fig-
ure 4A), nucleosome pull-downs withWTHP1 and HP1
mutants carrying the inactivating mutations in the chromo
(V22M) and chromo shadow (I165K,W174A) domains de-
scribed above (Figure 4B), and titration experiments with
the WT proteins (Supplementary Figure S5) demonstrate
that KDM2A is able to recruit HP1 to chromatin in a
H3K9me3-independent manner via a LxVxL/CSD interac-
tion.
Interestingly, we also observed that while the HP1
W174A mutant in the CSD could not be recruited to un-
modified nucleosomes through KDM2A (Figure 4B, lane
15) it was still able to bind to H3K9me3-modified nucle-
osomes on its own (Figure 4B, lane 10). This binding was
not detected in the I165K mutant (Figure 4B, lane 9). In
contrast to the I165Kmutant, which is deficient in cofactor
binding to the CSD and in HP1 dimerization, the W174A
mutant is only deficient in cofactor binding but retains the
ability to dimerize (30,33). This finding implies a crucial role
for the dimerization of HP1 in nucleosome recognition.
Taken together these observations suggest a complex reg-
ulation of KDM2A binding to chromatin, which is modu-
lated by both DNA methylation and the presence of H3K9
tri-methylation and HP1. Our data also demonstrate an
H3K9me3-independent recruitment mechanism for HP1
through KDM2A.
The ability of both proteins to bridge between nucleo-
somes and the respective other factor results in the for-
mation of a complex recruitment circuit on chromatin. To
demonstrate that this binding loop is also operational on
native chromatin in vivo we made use of the observation
that KDM2A preferentially localises to DAPI dense peri-
centromeric heterochromatin foci in mouse cells that are de-
void of DNA methylation (7). We expressed FLAG-GFP-
tagged WT KDM2A or the ZnF, PHD or HP1-binding
motif mutants in wild-type mouse ES cells that were ei-
ther left untreated or treated with the DNMT1-inhibitor 5-
Azacytidine to reduce the levels of DNAmethylation (Sup-
plementary Figure S6). We then analysed the nuclear lo-
calization of KDM2A by immunofluorescence against the
GFP-tag (Figure 5A andB). In untreated cells all constructs
showed a diffuse nuclear distribution due to high DNA
methylation levels. In 5-Azacytidine-treated cells, however,
WT KDM2A was found to localize to DAPI dense hete-
rochromatin foci in the vast majority of cells similar to the
localization observed in DNMT1−/− mouse embryonic fi-
broblasts (7). This localization to DAPI foci was not ob-
served for the S603D mutant confirming that the recog-
nition of unmethylated CpGs by the ZnF is critically im-
portant for KDM2A to localize to the pericentromeric re-
peats (Figure 5B). Importantly the localization of the HP1
binding-deficient V801A/L803A mutant to the pericen-
tromeric heterochromatin was strongly reduced in the 5-
Azacytidine-treated cells (Figure 5B). The mutant in the
PHD finger also showed reduction in recruitment although
not to the extent seen in the V801A/L803A mutant. Fur-
thermore, 5-Azacytidine treatment of Suv39h dn ES cells
in which both genes (Suv39h1 and Suv39h2) coding for the
H3K9-methyltransferase SUV39H are deleted (17) did not
result in a dramatic increase of localization ofWTKDM2A
to DAPI foci as seen in the wild type cells. The Suv39h dn
ES cells show reduced DNA methylation and lack H3K9
tri-methylation at pericentromeric heterochromatin and as
a consequence HP1 proteins are no longer found at the
pericentromeric repeats (34) (Figure 5A). These results con-
firm that also in vivo KDM2A preferentially localises to
H3K9me3- andHP1-marked chromatin whenDNAmethy-
lation levels are low and that both conditions need to bemet
for effective targeting. In addition to the CXXC-ZnF that
targets KDM2A to unmethylatedGpGs, the interaction be-
tween KDM2A and HP1 is critical for this recruitment.
Furthermore, we could demonstrate that KDM2A is able
to tetherHP1 proteins to chromatin in vivo bymaking use of
a cell-based fluorescent-three-hybrid (F3H) assay (20) (Fig-
ure 6A, B and Supplementary Figure S7A-D). For this as-
say FLAG-GFP-tagged KDM2A and red fluorescent pro-
tein (mRuby2) fused HP1 were co-expressed in BHK cells
and KDM2A was targeted to a lac operator (lacO) array
inserted into the genome by a co-transfected GBP-LacI
anchor. Localization of GFP-KDM2A and mRuby2-HP1
to the lacO array was then detected by fluorescence mi-
croscopy. Using the various KDM2A and HP1 constructs
described above confirms that KDM2A is able to recruit
all HP1 isoforms to chromatin also in vivo (Supplementary
Figure S7A and S7D) and that the interaction is mediated
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Figure 5. The interaction betweenKDM2AandHP1 is required for target-
ing of KDM2A to heterochromatic repeats in vivo. (A) KDM2A localizes
to pericentromeric heterochromatin in the presence of HP1 when DNA is
unmethylated.Mouse ES cells were transfected with a FLAG-GFP-tagged
KDM2A expression construct and treated with 0.25 M 5-Azacytidine
(5-AzaC) for 24 hours to demethylate the DNA. The effectiveness of the
5-AzaC treatment was tested by restriction digest of genomic DNA (see
Supplementary Figure S6). Localization of FLAG-GFP-KDM2A and en-
dogenous HP1 to DAPI-stained heterochromatic foci was then detected
by immunofluorescence. In untreated cells KDM2A shows diffuse stain-
ing throughout the nucleus. In 5-AzaC-treated WT ES cells, however,
KDM2A co-localizes with HP1 in heterochromatic foci in the great ma-
jority of cells. This 5-AzaC-induced targeting of KDM2A to DAPI foci is
reduced in Suv39h dn ES cells deficient for the H3K9 methyltransferases
SUV39H1/2 in which HP1 does not localize to pericentromeric hete-
rochromatin. (B) Targeting of KDM2A to pericentromeric heterochro-
matin requires interaction with HP1. WT and Suv39h dn mouse ES cells
were transfected with FLAG-GFP-tagged KDM2A WT and mutant ex-
pression constructs and treated with 5-Azacytidine as indicated. The lo-
calization of FLAG-GFP-KDM2A and endogenous HP1 was then de-
termined by immunofluorescence as in Figure 5A. Cells were counted and
scored based on localization ofKDM2A toDAPI-stained heterochromatic
foci. The targeting of KDM2A to DAPI foci observed for the WT in the
majority of 5-AzaC-treated WT ES cells is absent in the S603D mutant
and strongly reduced in the PHD C>A and V801A/L803A mutants. Het-
erochromatic localization of WT KDM2A is reduced to similar levels in
Suv39h dn ES cells. The effectiveness of the 5-AzaC treatment was tested
by restriction digest of genomic DNA (see Supplementary Figure S6).
by the HP1-binding motif in KDM2A (Figure 6A and Sup-
plementary Figure S7C) and the CSD in HP1 (Figure 6B
and Supplementary Figure S7D).
The HP1 binding motif is conserved and enriched for cancer
mutations
In search of evidence for a biological significance of the
HP1 interaction we performed database searches for single
nucleotide polymorphisms (SNPs) and disease-associated
point mutations in KDM2A. Disease-associated single nu-
cleotide variants (SNVs) resulting in harmful amino acid
exchanges are often found concentrated in functionally im-
portant domains of their gene products. Computational
analysis of missense SNVs in KDM2A deposited in the
public COSMIC (24) and cBioPortal/TCGA (25,26) can-
cer mutation databases indeed indicates an accumulation of
cancer-associated SNVs in the region of the HP1 binding
motif (Figure 7A and Supplementary Table S1). The mu-
tation density over the HP1 motif is similar to the one ob-
served over the catalytic centre of the JmjC demethylase do-
main. Comparison of the peptide sequences of KDM2Aor-
thologues in different species further indicates that the HP1
interaction motif is perfectly conserved in vertebrates. This
conservation is not observed in KDM2B and Fbxl19, close
paralogues of KDM2A that differ significantly in their pep-
tide sequences in the region between the PHD domain and
the F-box (Figure 7A and Supplementary File 1). The high
cancer mutation density and the evolutionary conservation
of the HP1 binding motif suggest an important role for
the HP1 interaction in the biological function of KDM2A
alongside the H3K36 demethylase activity. To test whether
any of the cancer mutations affect the interaction between
KDM2A and HP1 we introduced several mutations found
in the vicinity of the HP1 binding motif into our FLAG-
GFP-KDM2A expression construct. These mutants were
then expressed in 293T cells, immobilized on FLAG-affinity
beads, and used in quantitative pull-down assays to com-
pare their binding to recombinant HP1 relative to WT
KDM2A. This screen revealed that some mutations just
N-terminal of the motif indeed impair the interaction be-
tween KDM2A and HP1 (Supplementary Figure S8A and
S8B). The strongest effect was observed for the K793Nmu-
tant found in intestinal cancer which showed∼50% reduced
HP1 binding compared toWTKDM2A (Figure 7B and C).
These mutations appear to modulate and not completely
disrupt the interaction between KDM2A and HP1 suggest-
ing a deregulation rather than loss of function of KDM2A
caused by certain cancer mutations.
Inactivating theHP1 interactionmotif abolishes the KDM2A
overexpression phenotype in zebrafish embryos
As shown before KDM2A preferentially localizes to hete-
rochromatic foci in cells with reduced levels of DNAmethy-
lation (7). In addition,KDM2Aknock outmice display em-
bryonic lethality, which demonstrates an important func-
tion forKDM2A in embryonic development (35). Early em-
bryonic cell divisions are characterized by large-scale ge-
nomic demethylation events and re-establishment of tissue-
specific DNA methylation patterns during differentiation
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Figure 6. KDM2A can tether HP1 to chromatin in vivo. (A) Analysis of the KDM2A-mediated recruitment of HP1 to chromatin in a cell-based F3H
assay. FLAG-GFP-tagged WT KDM2A and different mutants were expressed together with mRuby2-fused HP1 and a GBP-LacI anchor construct in
BHK cells harbouring a genomic lacO array. The GBP-LacI fusion protein anchors the GFP tagged KDM2A mutants to the lacO array and shows a
green spot in the nucleus (second column, filled arrow head). mRuby2-fused HP1 was recruited to the lacO spot according to its interaction affinity with
the respective KDM2A mutants (third column, arrowhead). The KDM2A V801A/L803A mutation shows a significant reduction of the interaction with
HP1. Line intensity profiles of the GFP and mRuby2 are shown next to the image. Scale bar equals to 5 m. Quantifications of HP1 binding relative to
KDM2A binding can be found in Supplementary Figure S7C. (B) Test of the interaction between KDM2A and HP1 point mutants. While the V22M
mutation of HP1 has no obvious impact on the interaction (third column, filled arrowhead), the I165K and W174A mutations abolish the interaction
between HP1 and KDM2A (third column, open arrowhead). For quantifications see Supplementary Figure S7D.
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Figure 7. The HP1 interaction is integral to the biological function of KDM2A. (A) Domain-specific patterns of conservation and single nucleotide
variations in KDM2A.Missense variants segregating in the human population (SNPs, green ticks) or present in a collection of sequenced tumours (cancer
SNVs, black ticks) are indicated in relation to the linear domain architecture of humanKDM2A.Correspondingly coloured density plots highlight the anti-
correlated incidence of SNPs and cancer SNVs across KDM2A domains (SNP/SNV density). Identical amino acids across different subsets of KDM2A
orthologs/gene family members are illustrated below for individual residues (ticks). A Sequence alignment of the region surrounding the HP1 binding
motif (LTVTL) demarcated by dotted lines indicates conservation of the motif in KDM2A orthologues but not KDM2B and Fbxl19. A full alignment
of KDM2A orthologues spanning the whole protein sequence is provided in Supplementary File 1. (B) The K793N cancer mutation impairs binding of
HP1 to KDM2A. FLAG-GFP-tagged KDM2A WT or the K793N cancer mutant were expressed in 293T cells and captured on FLAG-affinity beads.
The immobilized KDM2A proteins were then incubated with different amounts of recombinant HP1 as indicated. 40% of the pull-down reactions were
resolved by SDS-PAGE and bound proteins detected by immunoblot. Titration of HP1 indicates reduced binding to the K793N mutant compared to
KDM2AWT. (C) Quantification of HP1 binding to WT KDM2A and the K793N mutant. The FLAG and HP1 immunoblots shown in Figure 7B were
quantified using the chemiluminescence signals associated with the full length FLAG-GFP-KDM2A and HP1 bands. HP1 signals were normalized
against the WT KDM2A pull-down with 1 g HP1 using the FLAG (KDM2A) signals obtained for the individual pull-downs as a relative measure
for loading. The figure shows the mean and standard deviation of three independently performed experiments plotted on a logarithmic (log10) scale.
Asterisks mark samples in which binding of HP1 to the K793Nmutant differs significantly from theWT (P-value< 0.05 by unpaired t-test). The K793N
mutant shows ∼50% reduced binding over a wide range of HP1 concentrations. (D) Loss of function of the KDM2A V801A/L803A mutant. Box plot
of overexpression phenotypes caused by injecting 3.6 nl of 62.5 ng/l mRNA of GFP and three human KDM2A constructs into zebrafish embryos shows
that there was no significant difference in phenotype between GFP and V801A/L803A mutant KDM2A, whereas in three out of four injections both
H212A mutant KDM2A and WT KDM2A showed significantly more abnormal embryos at 24 h.p.f. than the GFP control. Statistical analyses of the
individual overexpression experiments can be found in Supplementary Figure S9C–E.
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processes (36). The interaction between KDM2A and HP1
might, therefore, be relevant during certain ‘windows of
opportunity’ in early developmental processes when the
genome is unmethylated. We therefore sought an experi-
mental system in which the impact of the HP1 interaction
on the function ofKDM2Acould be tested during early em-
bryonic development in vivo. For this, zebrafish is a suitable
model organism as embryos develop outside the body and
the effects of the expression of exogenous proteins on early
embryonic development can be readily observed. To test the
relevance of the HP1 interaction for KDM2A function we
therefore overexpressed wild-type and mutant versions of
FLAG-GFP-tagged human KDM2A by injecting mRNA
into one-cell stage wild-type zebrafish embryos. First we
confirmed expression of all constructs by scoring GFP flu-
orescence at the dome stage (Supplementary Figure S9A).
We then tested for an overexpression phenotype by inject-
ing 3.6 nl of 62.5 ng/l mRNA from each construct into at
least 150 embryos with GFP mRNA as the control (Figure
7D and Supplementary Figure S9C–E). This was repeated
four times for each construct. We scored the embryos for
phenotypic abnormalities (Supplementary Figure S9B) at
24 h post fertilization (h.p.f.) after excluding any embryos
that were unfertilized or appeared damaged on the day of
the injection. We found a significant increase in the number
of embryos displaying an abnormal phenotype in three out
of four injections for both the wild-type KDM2A and the
JmjC demethylase-inactivating H212A mutant compared
to the GFP control (Figure 7D). By contrast, there was
no statistically significant difference between the GFP con-
trol and the V801A/L803A mutant with the inactivated
HP1 interaction motif. This demonstrates that in this in
vivo overexpression assay the HP1 interaction is essential
for the function of KDM2A, while the demethylase activity
is largely dispensable. This strongly suggests that KDM2A
functions to a large extent through its interaction with HP1
proteins.
DISCUSSION
DNAand histonemodifications are fundamental to the reg-
ulation of gene expression and the structural organization
of chromosomes. Together, these modifications create dis-
tinct local chromatin environments that are interpreted by
epigenetic factors. In order to integrate information from
multiple modifications epigenetic readers must be able to
engage in multivalent interactions with multiple binding
sites on chromatin. In this study we have used in vitro bio-
chemical and cell-based approaches to dissect how the his-
tone H3K36 demethylase KDM2A decodes different nucle-
osomal DNA and histone modification states.
Like many epigenetic factors KDM2A is a highly modu-
lar protein with a complex domain structure. Based on our
previous findings that KDM2A can recognize H3K9me3-
modified chromatin via HP1 proteins (3) we have mapped
the domains in KDM2A that are necessary for chromatin
binding. We have identified an extended chromatin recog-
nition module within KDM2A that allows it to read out
the nucleosomalDNAand histonemodification status. This
‘nucleosome interaction module’ spans from the CXXC-
ZnF to a newly identified variant HP1 interaction motif
downstream of the PHD domain that enables KDM2A to
directly bind to HP1. While it has been established that
the CXXC-ZnF mediates binding to unmodified CpG din-
ucleotides (6,7) we also find that the PHD domain is neces-
sary for nucleosome recognition by KDM2A. Whether the
PHD domain is directly involved in nucleosome contacts
or whether it provides structural support for other parts
of the protein remains to be determined. Our experiments
show that the direct interaction of KDM2A with CpG din-
ucleotides and HP1 enables complex binding dynamics be-
tween both factors on chromatin that are modulated by
DNA- and H3K9-methylation. The multivalent interaction
leads to preferential targeting of KDM2A to H3K9me3-
modified chromatin that is decorated with HP1 and con-
tains unmethylated CpGs, and to reduced binding when the
DNA is methylated. Importantly, the presence of KDM2A
on chromatin containing unmethylated DNA also enables
recruitment of HP1 in an H3K9me3-independent manner.
Evolutionary conservation and an enrichment of cancer-
associated single nucleotide variations that potentially in-
terfere with the KDM2A/HP1 interaction indicate an im-
portant biological function for the HP1 binding motif. Mu-
tating the LxVxL motif leads to loss of activity of KDM2A
in an in vivo overexpression assay in zebrafish embryos, pre-
sumably through disrupting the interaction with endoge-
nous zebrafishHP1 proteins, demonstrating that HP1 bind-
ing plays a major role for the function of KDM2A.
KDM2A has been shown to be involved in the silenc-
ing of centromeric satellite repeats (8) and of rRNA genes
(5,9). The ability to directly recruit HP1 to unmodified
chromatin suggests a function for KDM2A as an impor-
tant factor in the de novo establishment or maintenance
of silenced chromatin (Figure 8). Indeed, KDM2A prefer-
entially localises to pericentromeric heterochromatin when
DNA is unmethylated (7) and loss of KDM2A results
in disruption of heterochromatin (8). The CXXC-ZnF al-
lows KDM2A to be targeted to ‘naı¨ve’ chromatin regions
containing unmethylated CpG dinucleotides and no pre-
existing repressive histone modifications. In addition to
erasingH3K36methylationKDM2A could act as a landing
platform for HP1, which in turn would result in the recruit-
ment of H3K9-methyl transferases, leading to deposition
of H3K9-methylation and a reinforcement of HP1 bind-
ing. Subsequent recruitment of DNMTs (27,28) through
HP1 would result in the deposition of CpG-methylation
on the DNA, which would lead to the destabilization of
the KDM2A/DNA interaction and ultimately eviction of
KDM2A. KDM2A-mediated recruitment of HP1 might,
therefore, be the transient initial trigger for a feedback loop
resulting in establishment of H3K9 and CpG methylation
to form ‘mature’ heterochromatin. Despite the overall sim-
ilarity in peptide sequence between KDM2A and its close
paralogueKDM2B this ability to recruit HP1 to naı¨ve chro-
matin is most likely limited to KDM2A since the HP1 in-
teraction motif is not conserved in KDM2B.
Taken together, our experiments show a complex regula-
tion of nucleosome binding byKDM2Aand that a direct in-
teraction between KDM2A and HP1 is integral to its func-
tion. Through this interactionKDM2A has the potential to
be directly involved in heterochromatin regulation. Defects
in establishing and maintaining heterochromatin would re-
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Figure 8. Model for KDM2A-mediated establishment of heterochromatin. The CXXC-Znf enables KDM2A to bind chromatin containing no pre-existing
DNA and histone modifications (top). Binding of HP1 to the KDM2A LTVTLmotif establishes an alternative to the HP1 recruitment mechanism via the
H3K9me3-modification deposited by H3K9 lysine methyltransferases (KMTs) that does not require the K3K9me3 mark. Subsequent deposition of the
H3K9me3-modification by H3K9 KMTs leads to reinforced HP1 binding and a stabilization of the KDM2A/HP1/nucleosome interaction. The ability
of HP1 to recruit DNMTs leads to deposition of CpG methylation (black pinheads) which results in loss of KDM2A leaving behind DNA-methylated,
H3K9me3-modified and HP1-decorated heterochromatin (bottom).
sult in transcriptional deregulation and genomic instabili-
ties that could contribute to the cancerous phenotypes ob-
served in cells with aberrant KDM2A expression (8,10–14).
Although the exact contribution of the HP1 interaction to
the in vivo role of KDM2A remains to be established, it is
becoming evident that KDM2A has important functions
beyond its histone demethylase activity. Recent advances
in genome engineering technologies will enable a detailed
analysis of its various activities by introducing inactivating
point mutations into its functional domains and studying
the effects in in vivo model systems. These studies will be
key to unraveling how the individual activities contribute
to the function of KDM2A in chromatin regulation and de-
velopment, and shed light on the role of KDM2A in cancer
formation.
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